等待开盘 11-04 09:30:00 美东时间
+0.120
+0.45%
今日重点评级关注:康托·菲茨杰拉德:维持Cabaletta Bio"超配"评级,目标价从15美元升至30美元;HC Wainwright & Co.:维持Invivyd"买入"评级,目标价从5美元升至10美元
11-03 20:20
Citigroup analyst Ben Gerlinger maintains Columbia Banking System (NASDAQ:COLB) with a Neutral and raises the price target from $26 to $28.
11-01 04:10
Ronald Farnsworth, Executive Vice President, CFO, to Step Down Ivan Seda, Deputy CFO, Appointed CFO, Effective December 31, 2025 TACOMA, Wash., Oct. 30, 2025 /PRNewswire/ -- Columbia Banking...
10-31 04:12
Companies Reporting Before The Bell • Altria Group (NYSE:MO) is projected to re...
10-30 19:12
Columbia Banking System Inc's (NYSE:COLB) short interest as a percent of float ...
10-29 21:00
JPMorgan is still Joshua Brown's favorite long-term investment, supported by strong Q3 earnings. Others also favor Illumina, Columbia & Alibaba.
10-21 20:25
今日重点评级关注:摩根大通:维持National Energy Services"超配"评级,目标价从10美元升至19美元;Piper Sandler:维持LENZ Therapeutics"超配"评级,目标价从51美元升至67美元
10-13 11:26
今日重点评级关注:富国银行:维持Kyverna Therapeutics"超配"评级,目标价从24美元升至27美元;Chardan Capital:维持Oculis Holding"买入"评级,目标价从33美元升至51美元
10-09 10:51
Barclays analyst Jared Shaw maintains Columbia Banking System (NASDAQ:COLB) with a Equal-Weight and lowers the price target from $30 to $29.
10-08 23:21
今日重点评级关注:Ascendiant Capital:维持Aytu BioPharma"买入"评级,目标价从12美元升至12.5美元;Oppenheimer:维持Immuneering"跑赢大市"评级,目标价从21美元升至30美元
09-26 09:45